📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Endomembrane targeting of human OAS1 p46 augments antiviral activity. (2021)

First Author: Soveg FW

Attributed to: COVID-19 GenOMICC-GENOMICS ENGLAND PARTNERSHIP funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7554/elife.71047

PubMed Identifier: 34342578

Publication URI: http://europepmc.org/abstract/MED/34342578

Type: Journal Article/Review

Volume: 10

Parent Publication: eLife

ISSN: 2050-084X